NO973482L - Fremgangsmåte ved syntese av analoger av paratyroihormon og paratyroidhormonrelaterte peptider - Google Patents
Fremgangsmåte ved syntese av analoger av paratyroihormon og paratyroidhormonrelaterte peptiderInfo
- Publication number
- NO973482L NO973482L NO973482A NO973482A NO973482L NO 973482 L NO973482 L NO 973482L NO 973482 A NO973482 A NO 973482A NO 973482 A NO973482 A NO 973482A NO 973482 L NO973482 L NO 973482L
- Authority
- NO
- Norway
- Prior art keywords
- parathyroid hormone
- analogues
- synthesis
- related peptides
- hormone related
- Prior art date
Links
- 108700020797 Parathyroid Hormone-Related Proteins 0.000 title 1
- 102000003982 Parathyroid hormone Human genes 0.000 title 1
- 108090000445 Parathyroid hormone Proteins 0.000 title 1
- 102000043299 Parathyroid hormone-related Human genes 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000199 parathyroid hormone Substances 0.000 title 1
- 229960001319 parathyroid hormone Drugs 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
- C07K1/026—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2332296P | 1996-07-30 | 1996-07-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO973482D0 NO973482D0 (no) | 1997-07-29 |
| NO973482L true NO973482L (no) | 1998-02-02 |
Family
ID=21814418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO973482A NO973482L (no) | 1996-07-30 | 1997-07-29 | Fremgangsmåte ved syntese av analoger av paratyroihormon og paratyroidhormonrelaterte peptider |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6849710B1 (no) |
| EP (1) | EP0822200B1 (no) |
| JP (1) | JP4229992B2 (no) |
| KR (1) | KR100518982B1 (no) |
| CN (1) | CN1293096C (no) |
| AR (2) | AR008094A1 (no) |
| AT (1) | ATE277080T1 (no) |
| AU (1) | AU731160B2 (no) |
| BR (1) | BR9704138A (no) |
| CA (1) | CA2206008C (no) |
| CO (1) | CO4650046A1 (no) |
| CZ (1) | CZ239697A3 (no) |
| DE (1) | DE69730787T2 (no) |
| DK (1) | DK0822200T3 (no) |
| ES (1) | ES2227639T3 (no) |
| HR (1) | HRP970416A2 (no) |
| HU (1) | HUP9701277A3 (no) |
| IL (1) | IL121391A0 (no) |
| MA (1) | MA24353A1 (no) |
| MX (1) | MX9705719A (no) |
| NO (1) | NO973482L (no) |
| NZ (1) | NZ328411A (no) |
| PE (1) | PE91998A1 (no) |
| PL (1) | PL321391A1 (no) |
| SG (1) | SG67408A1 (no) |
| TR (1) | TR199700714A2 (no) |
| TW (1) | TW505654B (no) |
| UY (1) | UY24651A1 (no) |
| YU (1) | YU32197A (no) |
| ZA (1) | ZA976555B (no) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04006728A (es) | 2002-01-10 | 2005-08-19 | Osteotrophin Llc | Tratamiento de desordenes oseos con medicamentos anabolicos esqueleticos. |
| US7378495B2 (en) * | 2002-10-21 | 2008-05-27 | Pevion Biotech, Ltd. | PTH-rP related peptide cancer therapeutics |
| CA2628945A1 (en) * | 2005-11-10 | 2007-05-24 | Board Of Control Of Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
| WO2007082890A1 (en) * | 2006-01-17 | 2007-07-26 | N.V. Organon | SELECTIVE ENZYMATIC HYDROLYSIS OF C-TERMINAL tert-BUTYL ESTERS OF PEPTIDES |
| KR20170067906A (ko) | 2006-10-03 | 2017-06-16 | 라디우스 헬쓰, 인코포레이티드 | 골 아나볼릭 단백질을 위한 약물 전달 방법 |
| USRE49444E1 (en) | 2006-10-03 | 2023-03-07 | Radius Health, Inc. | Method of treating osteoporosis comprising administration of PTHrP analog |
| US7803770B2 (en) | 2006-10-03 | 2010-09-28 | Radius Health, Inc. | Method of treating osteoporosis comprising administration of PTHrP analog |
| US8563513B2 (en) | 2009-03-27 | 2013-10-22 | Van Andel Research Institute | Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use |
| JP2013512688A (ja) | 2009-12-07 | 2013-04-18 | ミシガン テクノロジカル ユニバーシティ | クロクマの副甲状腺ホルモン及びクロクマの副甲状腺ホルモンを使用する方法 |
| CN102731643A (zh) * | 2012-06-26 | 2012-10-17 | 深圳翰宇药业股份有限公司 | 一种治疗骨质疏松多肽的制备方法 |
| CN102993293B (zh) * | 2012-12-05 | 2014-05-07 | 深圳翰宇药业股份有限公司 | 一种特立帕肽醋酸盐的纯化方法 |
| ES2624961T3 (es) | 2013-03-21 | 2017-07-18 | Sanofi-Aventis Deutschland Gmbh | Síntesis de productos de péptido que contienen imida cíclica |
| AU2014234400B2 (en) | 2013-03-21 | 2017-11-16 | Sanofi-Aventis Deutschland Gmbh | Synthesis of hydantoin containing peptide products |
| CN104530198B (zh) * | 2014-12-09 | 2017-09-15 | 兰州大学 | 一种片段缩合制备醋酸去氨加压素的方法 |
| IL255148B2 (en) | 2015-04-29 | 2023-04-01 | Radius Pharmaceuticals Inc | 1901 rad for use in a method to inhibit a cancerous growth or induce tumor regression in a patient who is resistant to the drug and/or has cancer positive for an estrogen receptor alpha mutation |
| CN117417263A (zh) | 2017-01-05 | 2024-01-19 | 雷迪厄斯制药公司 | Rad1901-2hcl的多晶型形式 |
| US10996208B2 (en) | 2017-04-28 | 2021-05-04 | Radius Health, Inc. | Abaloparatide formulations and methods of testing, storing, modifying, and using same |
| WO2019175173A1 (en) * | 2018-03-12 | 2019-09-19 | Fresenius Kabi Ipsum S.R.L. | Process for the manufacture of pthrp analogue |
| CN112423844A (zh) | 2018-07-04 | 2021-02-26 | 雷迪厄斯制药公司 | Rad1901-2hcl的多晶型形式 |
| CN111057139B (zh) * | 2018-10-17 | 2023-12-22 | 南京华威医药科技集团有限公司 | 一种制备特立帕肽的新工艺 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3886132A (en) * | 1972-12-21 | 1975-05-27 | Us Health | Human parathyroid hormone |
| FR2550204B1 (fr) * | 1983-08-05 | 1987-11-13 | Toyo Jozo Kk | Derives peptidiques de (nle8,nle1b, tyr34)-h-pth |
| WO1992000753A1 (en) * | 1990-07-13 | 1992-01-23 | The Regents Of The University Of California | PARATHYROID HORMONE ANALOGUES MODIFIED AT POSITIONS 3, 6 or 9 |
| GB9020544D0 (en) * | 1990-09-20 | 1990-10-31 | Sandoz Ltd | Improvements in or relating to organic compounds |
| US5589452A (en) * | 1992-07-14 | 1996-12-31 | Syntex (U.S.A.) Inc. | Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| CN1070500C (zh) * | 1993-07-13 | 2001-09-05 | 森德克斯(美国)股份有限公司 | 甲状旁腺激素类似物和甲状旁腺激素相关肽：合成和治疗骨质疏松症的用途 |
| CO4410206A1 (es) * | 1994-07-28 | 1997-01-09 | Sandoz Ag | DERIVADOS DE PTH o PTHrP, SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN |
-
1997
- 1997-07-10 TW TW086109753A patent/TW505654B/zh active
- 1997-07-18 CA CA002206008A patent/CA2206008C/en not_active Expired - Lifetime
- 1997-07-21 PE PE1997000645A patent/PE91998A1/es not_active Application Discontinuation
- 1997-07-23 EP EP97112595A patent/EP0822200B1/en not_active Expired - Lifetime
- 1997-07-23 HU HU9701277A patent/HUP9701277A3/hu unknown
- 1997-07-23 DE DE69730787T patent/DE69730787T2/de not_active Expired - Lifetime
- 1997-07-23 DK DK97112595T patent/DK0822200T3/da active
- 1997-07-23 SG SG1997002618A patent/SG67408A1/en unknown
- 1997-07-23 ES ES97112595T patent/ES2227639T3/es not_active Expired - Lifetime
- 1997-07-23 AT AT97112595T patent/ATE277080T1/de active
- 1997-07-23 ZA ZA9706555A patent/ZA976555B/xx unknown
- 1997-07-24 IL IL12139197A patent/IL121391A0/xx unknown
- 1997-07-24 NZ NZ328411A patent/NZ328411A/xx unknown
- 1997-07-24 JP JP19807297A patent/JP4229992B2/ja not_active Expired - Lifetime
- 1997-07-25 YU YU32197A patent/YU32197A/sh unknown
- 1997-07-25 HR HR60/023,322A patent/HRP970416A2/hr not_active Application Discontinuation
- 1997-07-28 CZ CZ972396A patent/CZ239697A3/cs unknown
- 1997-07-28 CO CO97042932A patent/CO4650046A1/es unknown
- 1997-07-28 AR ARP970103413A patent/AR008094A1/es not_active Application Discontinuation
- 1997-07-29 KR KR1019970035861A patent/KR100518982B1/ko not_active IP Right Cessation
- 1997-07-29 PL PL97321391A patent/PL321391A1/xx unknown
- 1997-07-29 NO NO973482A patent/NO973482L/no not_active Application Discontinuation
- 1997-07-29 MX MX9705719A patent/MX9705719A/es active IP Right Grant
- 1997-07-29 CN CNB971154686A patent/CN1293096C/zh not_active Expired - Lifetime
- 1997-07-29 MA MA24742A patent/MA24353A1/fr unknown
- 1997-07-29 AU AU32362/97A patent/AU731160B2/en not_active Ceased
- 1997-07-29 UY UY24651A patent/UY24651A1/es not_active Application Discontinuation
- 1997-07-30 US US08/903,124 patent/US6849710B1/en not_active Expired - Lifetime
- 1997-07-30 BR BR9704138A patent/BR9704138A/pt active Search and Examination
- 1997-07-30 TR TR97/00714A patent/TR199700714A2/xx unknown
-
1999
- 1999-02-16 AR ARP990100625A patent/AR016981A2/es not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO973482D0 (no) | Fremgangsmåte ved syntese av analoger av paratyroihormon og paratyroidhormonrelaterte peptider | |
| NO972781D0 (no) | Aerosolformuleringer av peptider og proteiner | |
| BR9607669A (pt) | Derivado de hormõnio de peptídeo e processo de proporcionar o mesmo | |
| NO984947D0 (no) | Avisingsmiddel og fremgangsmÕte ved anvendelse av dette | |
| NO974671D0 (no) | Fremgangsmåte til å isolere en proteinsammensetning fra en muskelkilde og proteinsammensetning | |
| NO996551L (no) | Forbedrete anti-IgE-antistoffer og fremgangsmåte for forbedring av polypeptider | |
| EP0842293A4 (en) | PEPTIDE LIBRARY AND SCREENING PROCEDURE | |
| EP0826170A4 (en) | METHOD AND APPARATUS FOR IMPROVING THE PERFORMANCE OF A PROCESSOR | |
| EP0996627A4 (en) | SOLUTION PHASE SYNTHESIS OF OLIGONUCLEOTIDES AND PEPTIDES | |
| NO20003312D0 (no) | Gamma-glutamyl og beta-aspartyl inneholdende immunmodulator- forbindelser og fremgangsmÕter derav | |
| IL127153A0 (en) | Fragments of leptin (ob protein) | |
| DK0839153T3 (da) | Fremgangsmåde til fremstilling af peptider og N-carbamoyl-beskyttede peptider | |
| GB9929342D0 (en) | Multi-tier satellite system and method of operation | |
| ZA944090B (en) | Process for asymmetic total synthesis of camptothecln analogues and intermediates prepared thereby | |
| HUP0000320A3 (en) | Peptide and a method of obtaining it | |
| NO940801L (no) | Fremgangsmåte og komponenter for alternativ forskaling | |
| GB9803884D0 (en) | Method of fixing packing and structure for fixing packing | |
| NO972103D0 (no) | Eleutherobin og analoger av denne | |
| HRP940353A2 (en) | Tabacco expansion processes and apparatus therefor | |
| IL116973A0 (en) | Extraction of recombinant proteins | |
| NO963366D0 (no) | Peptider og fremgangsmåte for behandling av diabetes | |
| NO951479D0 (no) | Fremgangsmåte og anordning ved oppankret fartöy | |
| NO991730D0 (no) | Stang og fremgangsmÕte for fremstilling av denne | |
| IL105186A0 (en) | Partially modified and retroinverted tetrapeptide analogues of c-reactive protein fragments | |
| NO990018D0 (no) | Belegg og fremgangsmÕte for fremstilling derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |